» Articles » PMID: 38396434

High-Risk Sarcoidosis: A Focus on Pulmonary, Cardiac, Hepatic and Renal Advanced Diseases, As Well As on Calcium Metabolism Abnormalities

Overview
Specialty Radiology
Date 2024 Feb 24
PMID 38396434
Authors
Affiliations
Soon will be listed here.
Abstract

Although sarcoidosis is generally regarded as a benign condition, approximately 20-30% of patients will develop a chronic and progressive disease. Advanced pulmonary fibrotic sarcoidosis and cardiac involvement are the main contributors to sarcoidosis morbidity and mortality, with failure of the liver and/or kidneys representing additional life-threatening situations. In this review, we discuss diagnosis and treatment of each of these complications and highlight how the integration of clinical, pathological and radiological features may help predict the development of such high-risk situations in sarcoid patients.

Citing Articles

Neuropsychiatric manifestations of sarcoidosis.

Tana C, Bernardinello N, Raffaelli B, Garcia-Azorin D, Waliszewska-Prosol M, Tana M Ann Med. 2024; 57(1):2445191.

PMID: 39723989 PMC: 11703453. DOI: 10.1080/07853890.2024.2445191.


Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature-Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment.

Nicolosi S, Chernovsky M, Angoni D, Hughes M, Bandini G, McMahan Z Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338270 PMC: 11435091. DOI: 10.3390/ph17091106.


Is YouTube a sufficient source of information on Sarcoidosis?.

Buschulte K, El-Hadi S, Hoger P, Ganter C, Wijsenbeek M, Kahn N Respir Res. 2024; 25(1):334.

PMID: 39252025 PMC: 11386059. DOI: 10.1186/s12931-024-02956-2.

References
1.
Sawahata M, Yamaguchi T . Imaging Findings of Fibrosis in Pulmonary Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2022; 39(2):e2022018. PMC: 9437761. DOI: 10.36141/svdld.v39i2.12995. View

2.
Collins B, McClelland R, Ho L, Mikacenic C, Hayes J, Spada C . Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?. Respir Med. 2018; 144S:S20-S27. DOI: 10.1016/j.rmed.2018.08.008. View

3.
Cocconcelli E, Bernardinello N, Castelli G, Petrarulo S, Bellani S, Saetta M . Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis. Int J Mol Sci. 2023; 24(13). PMC: 10341418. DOI: 10.3390/ijms241310767. View

4.
Shlobin O, Kouranos V, Barnett S, Alhamad E, Culver D, Barney J . Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry. Eur Respir J. 2020; 55(5). DOI: 10.1183/13993003.01747-2019. View

5.
Nunes H, Uzunhan Y, Gille T, Lamberto C, Valeyre D, Brillet P . Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function. Eur Respir J. 2012; 40(3):750-65. DOI: 10.1183/09031936.00025212. View